Australia
· Delayed Price · Currency is AUD Pro Medicus Statistics
Total Valuation
Pro Medicus has a market cap or net worth of AUD 28.63 billion. The enterprise value is 28.45 billion.
| Market Cap | 28.63B |
| Enterprise Value | 28.45B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Feb 27, 2025 |
Share Statistics
Pro Medicus has 104.46 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 104.46M |
| Shares Outstanding | 104.46M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 48.82% |
| Owned by Institutions (%) | 14.24% |
| Float | 52.96M |
Valuation Ratios
The trailing PE ratio is 291.76 and the forward PE ratio is 211.47. Pro Medicus's PEG ratio is 4.93.
| PE Ratio | 291.76 |
| Forward PE | 211.47 |
| PS Ratio | 155.11 |
| PB Ratio | 128.82 |
| P/TBV Ratio | 142.31 |
| P/FCF Ratio | 282.63 |
| P/OCF Ratio | 281.52 |
| PEG Ratio | 4.93 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 211.33, with an EV/FCF ratio of 280.84.
| EV / Earnings | 289.46 |
| EV / Sales | 154.14 |
| EV / EBITDA | 211.33 |
| EV / EBIT | 212.67 |
| EV / FCF | 280.84 |
Financial Position
The company has a current ratio of 7.04, with a Debt / Equity ratio of 0.01.
| Current Ratio | 7.04 |
| Quick Ratio | 6.93 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 51.53% and return on invested capital (ROIC) is 43.45%.
| Return on Equity (ROE) | 51.53% |
| Return on Assets (ROA) | 32.90% |
| Return on Invested Capital (ROIC) | 43.45% |
| Return on Capital Employed (ROCE) | 51.42% |
| Revenue Per Employee | 2.68M |
| Profits Per Employee | 1.42M |
| Employee Count | 69 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 4.04 |
Taxes
In the past 12 months, Pro Medicus has paid 41.32 million in taxes.
| Income Tax | 41.32M |
| Effective Tax Rate | 29.60% |
Stock Price Statistics
The stock price has increased by +106.71% in the last 52 weeks. The beta is 0.45, so Pro Medicus's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +106.71% |
| 50-Day Moving Average | 251.20 |
| 200-Day Moving Average | 233.56 |
| Relative Strength Index (RSI) | 53.79 |
| Average Volume (20 Days) | 192,937 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pro Medicus had revenue of AUD 184.58 million and earned 98.29 million in profits. Earnings per share was 0.94.
| Revenue | 184.58M |
| Gross Profit | 184.30M |
| Operating Income | 133.78M |
| Pretax Income | 139.61M |
| Net Income | 98.29M |
| EBITDA | 134.05M |
| EBIT | 133.78M |
| Earnings Per Share (EPS) | 0.94 |
Balance Sheet
The company has 182.33 million in cash and 1.83 million in debt, giving a net cash position of 180.50 million or 1.73 per share.
| Cash & Cash Equivalents | 182.33M |
| Total Debt | 1.83M |
| Net Cash | 180.50M |
| Net Cash Per Share | 1.73 |
| Equity (Book Value) | 222.25M |
| Book Value Per Share | 2.13 |
| Working Capital | 205.41M |
Cash Flow
In the last 12 months, operating cash flow was 101.70 million and capital expenditures -397,000, giving a free cash flow of 101.30 million.
| Operating Cash Flow | 101.70M |
| Capital Expenditures | -397,000 |
| Free Cash Flow | 101.30M |
| FCF Per Share | 0.97 |
Margins
Gross margin is 99.85%, with operating and profit margins of 72.48% and 53.25%.
| Gross Margin | 99.85% |
| Operating Margin | 72.48% |
| Pretax Margin | 75.64% |
| Profit Margin | 53.25% |
| EBITDA Margin | 72.62% |
| EBIT Margin | 72.48% |
| FCF Margin | 54.88% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.18%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.18% |
| Dividend Growth (YoY) | 34.29% |
| Years of Dividend Growth | 9 |
| Payout Ratio | 42.51% |
| Buyback Yield | -0.02% |
| Shareholder Yield | 0.16% |
| Earnings Yield | 0.34% |
| FCF Yield | 0.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pro Medicus has an Altman Z-Score of 130.75 and a Piotroski F-Score of 5.
| Altman Z-Score | 130.75 |
| Piotroski F-Score | 5 |